Clopidogrel Prices

Clopidogrel Prices March 2024

In the first quarter of 2024, the price of the clopidogrel in in Korea reached $43,000/Ton. Similarly, in Chile, the clopidogrel prices hit $58,000/Ton.

Clopidogrel Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Clopidogrel Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of clopidogrel pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of clopidogrel at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of clopidogrel price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing clopidogrel price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Clopidogrel Market Analysis

The global clopidogrel market size reached US$ 12.4 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 30.1 Billion, at a projected CAGR of 10.40% during 2023-2032.

As the number of cases of cardiovascular diseases, specifically heart attacks and strokes, continues to rise, the demand for clopidogrel, a medication used to prevent blood clots, is also increasing, thereby driving the market growth. According to the Centers for Disease Control (CDC), 7 out of 10 U.S. deaths are caused by chronic disease, while roughly half of the country’s population has been diagnosed with a chronic illness, including heart disease, cancer, diabetes, AIDS, or other conditions classified by the medical community as preventable. This places clopidogrel among the most important medications for patients with high risk of thrombotic events, which are an essential component of cardiovascular treatment. Besides, the growing aging population, which is more susceptible to developing these conditions, is driving a high demand for these products. Ongoing advancements and current research in pharmaceutical formulations enhance clopidogrel’s clinical outcomes and risk-benefit ratio, increasing its utility among clinicians. These developments include the production of generic versions, making the medication more affordable and accessible to a larger number of patients. Additionally, approvals and reimbursement policies issued by organizations, particularly government bodies, play a significant role in the expansion of the market. For instance, Sanofi-aventis and Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for the antiplatelet agent PLAVIX(R) (clopidogrel bisulfate. This approval is aimed at reducing the overall mortality rate and the combined endpoint of re-infarction, stroke, or death in patients with acute ST-segment elevation myocardial infarction (STEMI). Also, the consciousness of health maintenance and the necessity to control cardiovascular consequences is increasing the demand for clopidogrel. The increasing awareness from governmental as well as non-governmental organizations’ sponsored healthcare campaigns ensures that users demand antiplatelet therapy. Factors related to economics like the growing investments on health care costs and advances in the health care industry, especially in the developing economies, are contributing to the expansion of the clopidogrel market. Furthermore, the diverse marketing strategies employed by different pharmaceutical companies involved in the distribution of clopidogrel are also enhancing market penetration.

Clopidogrel News

The report covers the latest developments, updates, and trends impacting the global clopidogrel market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in clopidogrel production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the clopidogrel price trend.

Latest developments in the Clopidogrel Industry:

• June 2023: Ascendia Pharmaceuticals has developed a novel nanoemulsion IV formulation for clopidogrel, which has received FDA Investigational New Drug (IND) approval. This formulation, created in partnership with AcuteBio, LLC, aims to enhance treatment for coronary artery disease (CAD), particularly during stent placements. Unlike oral doses, which take two to five hours to act, the IV delivery provides immediate onset, improving patient outcomes.
• Jan 2024: Cosmos Health Inc. has acquired a portfolio of 10 generic medications for approximately $3.5 million, enhancing its presence in the global generic drugs market, valued at over $400 billion. The drugs address various health issues, including diabetes and cardiac conditions, with manufacturing set to occur at its subsidiary, Cana Laboratories. Among the medications is clopidogrel, used for preventing blood clots. This acquisition supports Cosmos Health's goal of becoming a comprehensive pharmaceutical entity, expanding its international market reach and product offerings.

Product Description

Clopidogrel is an antiplatelet drug that is commonly prescribed to patients with cardiovascular conditions, including heart attacks and strokes, to prevent blood clot formation. This pharmaceutical agent has the mechanism of reducing the ability of platelets to coagulate and thus the risk of clot formation in arteries is minimized. Clopidogrel, a P2Y12 adenosine diphosphate (ADP) receptor antagonist, ensures long-term platelet inhibition. As an oral medication, it is convenient for patients to take and has been proven effective when combined with aspirin to enhance the antithrombotic effect. It is particularly valued for its prolonged prevention of further thrombotic episodes, making it a crucial component in the treatment of cardiovascular diseases.

Regional Coverage

The report provides a detailed analysis of the clopidogrel market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the clopidogrel price trend.

Global Clopidogrel Price

The report offers a holistic view of the global clopidogrel pricing trends in the form of clopidogrel price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of clopidogrel but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed clopidogrel demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Clopidogrel Price

In the European economy, the market price of clopidogrel was contributing to an increased demand of the product in the pharmaceutical sector. But they dropped significantly in the later periods due to enhancement in the supply side and demand restraints, along with contraction in degree of production downstream processing plants. Other factors influencing the changing prices in the region included rising shipping costs and the depreciation of the Euro. However, consumers benefited from an increased availability of commodities, which, in turn, reduced their supply as a primary price determinant.

Detailed price information for clopidogrel can also be provided for an extensive list of European countries.

North America Clopidogrel Price

Initially, the prices for clopidogrel bisulfate in North America went up because of the increased demand for clopidogrel bisulfate among pharmaceutical organizations and shipping expenses. Nevertheless, the prices continually fell as the freight costs reduced and the value of US dollar increased, leading to better purchasing capacity and better availability of commodities. Intensified pricing mechanisms together with enhanced trade activities, also enhanced and reduced the volatility of the market prices at the end of the period.

Specific clopidogrel historical data within the United States and Canada can also be provided.

Middle East and Africa Clopidogrel Price

The clopidogrel pricing trends in the Middle East and Africa are increasingly impacted by infrastructural developments and investments in the construction and transportation sectors. The region’s political climate and its effect on operational stability and security are also crucial in determining price trends. Additionally, the Middle East's strategic initiatives to diversify away from oil dependency and invest in mining and metal production capabilities are reshaping its market dynamics. In Africa, the availability of resources combined with foreign investment in mining projects heavily influences local and global clopidogrel supply and prices.

Region-wise data and information on specific countries within these regions can also be provided.

Asia Pacific Clopidogrel Price

In Asia pacific, clopidogrel bisulfate prices at the commencement of the year hiked because of high demand of new export orders coupled with the high shipping expenses. However, prices started coming down since regional absorption was not as good and there were less international enquires. The rationalization of freight charges, the availability, and the stiff competition that was exhibited among the suppliers was another factor that boosted the decrease in price hence, increasing the trade activities and overall consumer price by the close of the period.

This clopidogrel price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Clopidogrel Price

Latin America's clopidogrel market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in clopidogrel prices. Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting the region's ability to meet international demand consistently. Moreover, economic fluctuations and currency devaluation are critical factors that need to be considered when analyzing clopidogrel pricing trends in this region.

This comprehensive review can be extended to include specific countries within Latin America.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of clopidogrel pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting clopidogrel price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The clopidogrel price charts ensure our clients remain at the forefront of the industry.